Haemonetics (HAE) Tops Q1 EPS by 18c; Raises FY20 EPS Guidance Above Consensus

August 6, 2019 6:29 AM

Haemonetics (NYSE: HAE) reported Q1 EPS of $0.81, $0.18 better than the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found